Perioperative Chemotherapy with FLOT Improves Survival Among Patients with Resectable Oesophageal Adenocarcinoma By Ogkologos - February 10, 2025 625 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the ESOPEC study Source RELATED ARTICLESMORE FROM AUTHOR No OS Improvement with CDK4/6 Inhibitors Used in First- Compared with Second-Line Treatment in Patients with HR-positive, HER2-negative ABC Antitumour Activity of Rezatapopt Provides Proof of Concept for p53 Reactivation in Patients with TP53 Y220C-mutated Solid Tumours Rare Disease Day 2026: Advancing equity for people living with rare cancers in Europe MOST POPULAR Results of Continuous vs Intermittent Dosing Schedules of BRAF/MEK Inhibitor Combination... October 30, 2020 Efficacy and Safety of Datopotamab Deruxtecan in Patients with Pretreated Advanced/Metastatic... January 27, 2025 Targeted Therapy, Driven by Comprehensive Genomic Profiling and Molecular Tumour Board,... October 18, 2024 The Best And Worst Face Masks For COVID-19, Plus Face Masks... August 19, 2020 Load more HOT NEWS Why haven’t we cured cancer? Advances in Treating Kidney Cancer and Metastatic Prostate Cancer: Research from... FDA Approves Selinexor for Refractory or Relapsed Multiple Myeloma For Esophageal Cancer, Immunotherapy Likely to Play Larger Role
